50 likes | 240 Views
Baseline characteristics of study population. Brilakis ES et al. Am J Cardiol 2008;102:552-8. Biomarkers at baseline and at four months from study enrollment in different treatment groups. Brilakis ES et al. Am J Cardiol 2008;102:552-8.
E N D
Baseline characteristics of study population Brilakis ES et al. Am J Cardiol 2008;102:552-8
Biomarkers at baseline and at four months from study enrollment in different treatment groups Brilakis ES et al. Am J Cardiol 2008;102:552-8
Outcomes in patients with and without previous coronary artery bypass grafting Brilakis ES et al. Am J Cardiol 2008;102:552-8
Outcomes with intensive versus moderate statin therapy in patients with and without previous coronary artery bypass grafting in the PROVE IT-TIMI 22 and A to Z trials Brilakis ES et al. Am J Cardiol 2008;102:552-8
Kaplan-Meier estimate of the incidence of the PROVE IT-TIMI 22 primary end point Brilakis ES et al. Am J Cardiol 2008;102:552-8